Application for national approval of "Abigan" as a new corona treatment

Application for national approval of "Abigan" as a new corona treatment October 16, 13:31

Regarding the influenza drug Avigan, the company that developed the drug announced on the 16th that it has applied for national approval as a drug for the new coronavirus.

"Abigan" is an antiviral drug developed by Fujifilm Toyama Chemical Co., Ltd., which has been approved as a therapeutic drug for new influenza, and is expected to have therapeutic effects even with the new coronavirus.

Last month, the company announced the results of a clinical trial in patients with the new coronavirus, confirming that administration of the drug would reduce the time it takes for symptoms to improve and a PCR test to be negative by 2.8 days. I said it was possible.

In addition, the trial showed no other side effects than previously known, and there were no new safety concerns.

In response to this result, the company announced on the 16th that it has applied to the Ministry of Health, Labor and Welfare for official approval of Avigan as a treatment for the new coronavirus.

The Fujifilm Group commented, "By delivering therapeutic agents to patients with the new coronavirus as soon as possible, we will contribute to controlling the spread of infection and ending the epidemic."

As a therapeutic drug for the new coronavirus, "remdesivir", which has been developed as a therapeutic drug for Ebola hemorrhagic fever, has been approved, and the steroid drug "dexamethasone" is recommended.

Minister of Health, Labor and Welfare Tamura "Scrutinizing and judging safety and effectiveness"

At a press conference after the Cabinet meeting, Minister of Health, Labor and Welfare Tamura said, "I would like to make a final decision after carefully examining the safety and effectiveness. I do not look at the contents of the data for how long it will take. I don't know, but I am aware that it is an emergency and I will closely examine it. "